可吸收不透X线水凝胶隔离胰头与十二指肠的可行性研究
本研究在3具人体尸体上经开腹或EUS引导注射可吸收不透X线水凝胶,评估隔离胰头与十二指肠的可行性和理论剂量学优势;EUS引导下V20和V15降低,模型研究显示8 mm分离足以将V15、V20、V33降至可接受临床约束。
要点
- 尸体模型证实水凝胶可分离胰头与十二指肠,EUS引导可行。
- EUS引导下十二指肠V20和V15降低,PTV覆盖改善或相当。
- 模型研究显示8 mm分离足以使V15、V20、V33达临床约束。
核心结论
- 水凝胶分离胰头与十二指肠在尸体模型中可行,并可能支持SBRT或IMRT的剂量提升。
研究设计与样本
- 在3具人体尸体上经开腹(1例)或EUS引导(2例)注射可吸收不透X线水凝胶,行CT和 histologic确认。
主要发现
- 3例尸体分别实现平均0.9 cm、1.1 cm、0.9 cm的胰头-十二指肠分离。
- 2例EUS引导下V20从3.86 cm3降至0.36 cm3、从3.75 cm3降至1.08 cm3(约束<3 cm3)。
- 2例EUS引导下V15从7.07 cm3降至2.02 cm3、从9.12 cm3降至3.91 cm3(约束<9 cm3)。
- 注射前后PTV覆盖改善或相当。
- 基于60例SBRT计划的模型研究显示8 mm分离足以持续降低V15、V20、V33至可接受临床约束。
关键数值与推荐
- 十二指肠V20治疗约束<3 cm3,V15治疗约束<9 cm3。
- 8 mm分离在模型研究中足以使V15、V20、V33达可接受临床约束。
临床怎么用
- 该技术可能用于不可切除胰腺癌SBRT或IMRT中保护十二指肠并支持剂量提升,但需未来研究评估安全性和有效性。
局限性
- 研究基于3具尸体和模型计划,尚未在患者中评估安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed the feasibility and theoretical dosimetric advantages of an injectable hydrogel to increase the space between the head of the pancreas (HOP) and duodenum in a human cadaveric model. METHODS AND MATERIALS: Using 3 human cadaveric specimens, an absorbable radiopaque hydrogel was injected between the HOP and duodenum by way of open laparotomy in 1 case and endoscopic ultrasound (EUS) guidance in 2 cases. The cadavers were subsequently imaged using computed tomography and dissected for histologic confirmation of hydrogel placement. The duodenal dose reduction and planning target volume (PTV) coverage were characterized using pre- and postspacer injection stereotactic body radiation therapy (SBRT) plans for the 2 cadavers with EUS-guided placement, the delivery method that appeared the most clinically desirable. Modeling studies were performed using 60 SBRT plans consisting of 10 previously treated patients with unresectable pancreatic cancer, each with 6 different HOP-duodenum separation distances. The duodenal volume receiving 15 Gy (V15), 20 Gy (V20), and 33 Gy (V33) was assessed for each iteration. RESULTS: In the 3 cadaveric studies, an average of 0.9 cm, 1.1 cm, and 0.9 cm HOP-duodenum separation was achieved. In the 2 EUS cases, the V20 decreased from 3.86 cm3 to 0.36 cm3 and 3.75 cm3 to 1.08 cm3 (treatment constraint <3 cm3), and the V15 decreased from 7.07 cm3 to 2.02 cm3 and 9.12 cm3 to 3.91 cm3 (treatment constraint <9 cm3). The PTV coverage improved or was comparable between the pre- and postinjection studies. Modeling studies demonstrated that a separation of 8 mm was sufficient to consistently reduce the V15, V20, and V33 to acceptable clinical constraints. CONCLUSIONS: Currently, dose escalation has been limited owing to radiosensitive structures adjacent to the pancreas. We demonstrated the feasibility of hydrogel separation of the HOP and duodenum. Future studies will evaluate the safety and efficacy of this technique with the potential for more effective dose escalation using SBRT or intensity-modulated radiation therapy to improve the outcomes in patients with unresectable pancreatic cancer.
引用
- Rao AD, Feng Z, Shin EJ, et al. A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2017. PMID: 28943075. doi:10.1016/j.ijrobp.2017.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。